-
Targeted Social Media Use Could Expand Mesothelioma Knowledge Base
Technological advances in medicine have provided many victims of malignant mesothelioma with significantly longer survival times. Though the disease remains extremely challenging to treat, improved techniques and earlier detection have combined to the point where some of those diagnosed with the rare and fatal form of cancer are able to live several years beyond the
-
Mesothelioma Treatment Toll Goes Beyond Side Effects
Though many assume that the hardest thing about being treated for malignant mesothelioma is the side effects and the fear, when you ask a patient about their experience you are likely to hear a different story. Though these victims of asbestos exposure will no doubt discuss the nausea and hair loss of chemotherapy, the fatigue
-
Mesothelioma Surgeon Identifies Lymph Nodes Integral to Gauging Disease Progression
Thoracic surgeons are on the front lines of the battle against malignant pleural mesothelioma. These physicians not only work to help specific patients, but also report back to their colleagues about their findings in a constant effort to advance their understanding of the disease. They share what works and what doesn’t so that every mesothelioma
-
In NJ Mesothelioma Trial, Jury Told That Johnson & Johnson Knew of Asbestos in Talcum Powder
Malignant mesothelioma lawsuits have always centered on a single, basic premise: that companies whose products were contaminated with asbestos prioritized their profits over people’s health, and therefore are responsible for the illness that exposure to that asbestos caused. These lawsuits have generally been filed against manufacturers of commercial and industrial products used in high-heat settings
-
With Solution to Virotherapy’s Shortcomings, Researchers May Have a New Solution for Mesothelioma
Despite the many hurdles presented by malignant mesothelioma, researchers continue working to find a way to defeat this asbestos-related disease. Malignant mesothelioma is one of the most challenging forms of cancer that medical science has encountered. In addition to the condition having a remarkably long latency period and being incredibly aggressive, it also presents challenges
-
Senate Subpoenas Johnson & Johnson Following Mesothelioma and Ovarian Cancer Lawsuits
In the midst of thousands of personal injury lawsuits accusing them of culpability for cases of mesothelioma and ovarian cancer, consumer giant Johnson & Johnson has revealed that they have also received subpoenas from numerous federal agencies, including the Securities and Exchange Commission (SEC), the U.S. Department of Justice, and Senator Patty Murray. According to
-
Superior Court Upholds $9 Million Mesothelioma Verdict Against Ford Motor Company
In June of 2018, a mesothelioma lawsuit filed by Paula Knecht of New Mexico was heard by a jury. Mrs. Knecht’s husband Larry died of the asbestos-related disease in December of 2014, just 8 months after being diagnosed, and the lawsuit claimed that his illness was caused by his exposure to asbestos-contaminated products that he
-
Researchers Find 10-Minute, Water-Based Test, Could Benefit Those at Risk for Mesothelioma
Though their ultimate goal is finding a cure for malignant mesothelioma, if you were to ask researchers for a single tool that would help them more effectively treat mesothelioma patients they would likely ask for a fast and reliable diagnostic test. Australian researchers may have taken us one step closer to that goal, as a
-
Raising Mesothelioma Awareness on Rare Disease Day
Every year, people with rare disorders and their families, friends and communities mark Rare Disease Day, an initiative launched by the National Organization for Rare Disorders (NORD). In 2019, the day will be marked on February 28 with events, awareness programs and activities across the country. There are over 7,000 rare diseases that affect 25
-
Company’s Attempt to Void $14 Million Mesothelioma Verdict Denied by Court
When Celanese Corporation was told it owed $14 million to the family of a man who died of malignant mesothelioma, the company immediately appealed the verdict. Their issue was not whether they were responsible for Dennis Seay’s exposure to asbestos within the walls of their facility: they knew that he had worked at their plant
-
HIV Researcher Dies of Mesothelioma After Decades of Asbestos Exposure in NHS Hospitals
Mesothelioma has claimed the life of renowned HIV researcher and sexual health consultant Dr. Mags Portman at the age of 44. Portman, a London resident who has worked in NHS hospitals for over twenty years, has been credited with breakthroughs in the prevention of HIV through her pioneering work on the HIV PrEP program. It
-
Study Supports Use of Aggressive Surgery and Combination Treatment in Select Mesothelioma Patients
Though all physicians treating patients with mesothelioma have the same goal of providing their patients with the best possible outcome and longest possible survival, there are disagreements about how that should be achieved. Most agree that patients do best with a combination of surgery and other modalities such as chemotherapy and radiation therapy, but where
-
Talc Supplier Facing Thousands of Mesothelioma Claims Files for Bankruptcy
In a move reminiscent of so many other companies responsible for mesothelioma and other asbestos-related diseases, Imerys Talc America and two of their associated companies have filed for bankruptcy protection against the thousands of lawsuits currently filed against it. Imerys, the company that provided talc to Johnson & Johnson for use in their baby powder,
-
Positive Results Reported in Phase 1 Trial of Bavencio for Malignant Mesothelioma
One of the malignant mesothelioma treatment protocols generating the most enthusiasm is immunotherapy: the idea of weaponizing the body’s immune system against the aggressive form of cancer is truly exciting, especially when clinical trials of immunotherapeutic drugs deliver positive results. That is exactly what has happened with the Phase 1 clinical trial of immune checkpoint
-
New York City Contractor Ordered to Stand Trial in Mesothelioma Case
Mesothelioma victims have been very much in the news recently. This is in large part due to the attention being paid to claims against Johnson & Johnson’s Baby Powder and other big-name defendants. Though these companies are household names, they are not the only ones that have been responsible for innocent people being exposed to
-
Survey Shows Healthcare Professionals Views on Chemotherapy Provided to Mesothelioma Patients
If you are a patient who has been diagnosed with malignant mesothelioma, or someone in that patient’s circle of friends and loved ones, you likely assume that they are receiving the best treatment possible, with the goal of both extending their life and making them as comfortable as possible. But a new study published in
-
Native Americans Disproportionately Affected by Mesothelioma and Other Asbestos-Related Diseases
Mesothelioma is an equal opportunity disease. It impacts everybody who has been exposed to asbestos, regardless of age, gender, or other demographic information. However, not everybody is equally at risk for exposure to asbestos. It has long been known that there are certain occupations that historically had a higher degree of exposure to the carcinogenic
-
Australian Region Described As World’s Most Devastated by Mesothelioma
Pilbara, a beautiful region of Western Australia, has seen more asbestosis and mesothelioma diagnoses than nearly any other place in the world, and though entire towns have been wiped out by their exposure to asbestos, the problem struck the indigenous community particularly hard. Aboriginal People at Particular Risk Photos from the glory days of the
-
Spray-On Immunotherapy Treatment Could Boost Results of Pleural Mesothelioma Surgery
One of the most successful innovations in the treatment of malignant peritoneal mesothelioma has been the introduction of the HIPEC procedure that bathes the surgical field in a heated chemotherapy bath after tumors have been removed and before the surgeon closes. The protocol is thought to add an additional layer of protection for patients, preventing
-
Judge “Not Sympathetic” to Ford’s Attempt to Evade $9.1 Million Mesothelioma Verdict
Indicating that he was “not sympathetic” to arguments made by Ford Motor Company against having to pay a $9.1 million mesothelioma judgment, Delaware Superior Court Judge Ferris W. Wharton rejected arguments that the auto giant was not treated well in court and deserved a new trial. The case involved the death of Larry Knecht, a
